A review highlights the ongoing challenge of conduction disturbances (CDs) following transcatheter aortic valve replacement (TAVR), revealing that the incidence remains “in the double-digit range,” with permanent pacemaker implantation (PPI) rates exceeding 10%. 

According to a sub-analysis of the PROSPECT II trial, patients with recent non-ST elevation myocardial infarction (NSTEMI) and high baseline levels of high-sensitivity C-reactive protein (hsCRP) are more likely to have pan-coronary atherosclerosis and focal high-risk plaques. 

Findings from a new study reveal a notable national decline in aspirin use for cardiovascular disease prevention between 2015 and 2023, particularly in response to updated medical guidelines and recent clinical trials reviewing its routine use.

A new case report demonstrates the rare instance of a type A aortic dissection spontaneously sealing after transcatheter heart valve deployment, allowing for successful conservative management in a high-risk patient.

New research shows machine learning is useful in enhancing risk stratification for patients with aortic regurgitation (AR), including the description of 4 distinct phenoclusters within this patient population. 

Patients who receive 4-factor prothrombin complex concentrate (PCC) for bleeding complications during cardiac surgery have superior hemostatic and safety outcomes compared with patients who receive frozen plasma, a new analysis shows. 

Compared to surgery, transcatheter aortic valve replacement (TAVR) achieves similar valve hemodynamic performance and durability in low-risk patients with severe aortic stenosis (AS), according to new 5-year echocardiographic data from the PARTNER 3 trial. 

Primary care providers (PCPs) label vascular disease as one of the top three health crises facing the elderly population, but awareness is not prevalent in the public eye. Only one in three Americans have heard about the disease, survey results show. 

Subclinical liver cirrhosis associated with tricuspid regurgitation (TR) is linked with poor prognosis in tricuspid valve replacement (TTVR patients), despite TR abolishment, according to a new single-center, real-world analysis of Canadian patients.